학술논문
Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register
Document Type
Article
Author
Source
In Seminars in Arthritis and Rheumatism February 2024 64
Subject
Language
ISSN
0049-0172